Thank you to the 2022 ISPE Biotechnology Conference Program Committee for putting in so much time to create such a highly technical and informative experience—and today was only day 1 of 3!
As ISPE CEO And President Thomas Hartman, noted during welcoming remarks today, this is a group of subject matter experts unparalleled in the industry when it comes to biotech conference planning.
Narendra Bam, PhD, Senior Vice President, Medicine Development and Supply, GSK, explored biopharmaceutical manufacturing innovations on the horizon, highlighting examples from GSK’s manufacturing technology development portfolio of projects during his keynote presentation at the 2022 #ISPEBio Conference.
Watch this clip to hear Dr. Bam speak about how continuous manufacturing offers several key benefits to biopharmaceuticals.
Jasna Curak, Global Quality and External Collaboration Manager, Roche, explored this during her 2022 #ISPEBio Conference presentation "ATMPs - GMP Challenges."
Prudence Edwards, Double Degree Engineering Student (University of Queensland/Centrale Marseille), posed this question as she led the panel Q&A during the ISPE Think Tank session "Expanding Your Footprint: Opportunities in Biotech," presented by Women in Pharma® during the 2022 #ISPEBio Conference.
Watch this clip to hear what panelist Lindsey Daniel, PE, Product Operations Program Manager, Takeda, had to say.
During the closing session of the 2022 #ISPEBio Conference, keynote Juan Andres, Chief Technical Operations and Quality Officer, Moderna, discussed his company’s journey from start-up to scale-up, overcoming challenges, and moving into the future.